Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial
Introduction Do-it-yourself artificial pancreas system (DIY APS) is built using commercially available insulin pump, continuous glucose monitoring (CGM) and an open-source algorithm. Compared with commercial products, DIY systems are affordable, allow personalised settings and provide updated algori...
Saved in:
| Main Authors: | Hongrong Deng, Daizhi Yang, Wen Xu, Jinhua Yan, Ping Ling, Mengyun Lei, Beisi Lin, Zhigu Liu, Xubin Yang, Jing Lv |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/13/8/e073263.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial
by: Daizhi Yang, et al.
Published: (2020-01-01) -
Experiences and opinions of adults with type 1 diabetes on the android-based open-source closed-loop system in China: a qualitative study
by: Chaofan Wang, et al.
Published: (2025-01-01) -
Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
by: Bana Antonios, et al.
Published: (2022-01-01) -
Evaluating the pharmacokinetics and safety of blonanserin tablets and Lonasen®: a randomized, open-label, two-period, two-sequence, self-crossover phase I clinical trial
by: Bo Qiu, et al.
Published: (2025-01-01) -
Solid Pseudopapillary Neoplasms of the Pancreas: A Report of Two Cases
by: Dilip Dan, et al.
Published: (2014-01-01)